Focus reverse-payment cases on what reasonable drugmakers would have done, lawyer in Nexium case says
Plaintiffs suing pharmaceutical companies for allegedly delaying entry of generic drugs would be better served to focus on economic testimony regarding what a reasonable manufacturer would have done, said a lawyer...To view the full article, register now.
Already a subscriber? Click here to view full article